Dysregulation of Matrix Metalloproteinases and their Tissue Inhibitors by S100A4
Renate Elenjord, Hilde Ljones, Elisabeth Sundkvist, Thrina Loennechen, Jan Winberg
Abstract
Renate Elenjord, Hilde Ljones, Elisabeth Sundkvist, Thrina Loennechen, Jan Winberg
Abstract
The S100A4 protein as well as the matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) are associated with diseases such as arthritis and cancer. This mini review focuses on in vitro and in vivo studies indicating S100A4 involvement in regulation of MMPs and TIMPs, and the biological and pathobiological consequences of this regulation.
OpenAlex reports 17 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The S100A4 protein as well as the matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) are associated with diseases such as arthritis and cancer. This mini review focuses on in vitro and in vivo studies indicating S100A4 involvement in regulation of MMPs and TIMPs, and the biological and pathobiological consequences of this regulation.
Key concepts: Matrix metalloproteinase, In vivo, Cancer research, In vitro, Cell biology, Arthritis, Medicine, Chemistry